DOW JONES28,168.23-824.18 -2.84%
S&P 5003,247.37-90.38 -2.71%
NASDAQ9,276.16-300.43 -3.14%

Dr Reddy's Laboratories Earlier Reported Q3 EPS $0.63 Beats $0.51 Estimate, Sales $614M Up From $553M YoY

Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.51 by 23.53 percent. This is a 50 percent increase over earnings of $0.42 per share from

Benzinga · 01/27/2020 14:09

Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.51 by 23.53 percent. This is a 50 percent increase over earnings of $0.42 per share from the same period last year. The company reported $614 million in sales this quarter. This is a 11.03 percent increase over sales of $553 million the same period last year.